Home » Topics » Regulatory

Regulatory
RSS

Alza's Doxil approved in U.S. for treatment of refractory ovarian cancer

July 1, 1999

Genentech submits NDA to FDA for Nutropin Depot

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Fosamax receives FDA approval for glucocorticoid-induced osteoporosis

June 29, 1999

Ethyol approved by FDA for radiation-induced dry mouth

June 28, 1999

HIV protease inhibitor Agenerase now available in oral solution

June 28, 1999

Olanzapine effective in management of bipolar disorder

June 28, 1999

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

June 25, 1999

Daclizumab may have applications in uveitis therapy

June 25, 1999

FDA clears Cutivate cream for treatment of atopic dermatitis in children

June 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.